Purple Biotech Ltd.
PPBT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $7 | $14 | $15 | $11 |
| Short-Term Investments | $1 | $1 | $17 | $36 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $1 | $1 |
| Total Curr. Assets | $9 | $16 | $33 | $48 |
| Property Plant & Equip (Net) | $0 | $0 | $1 | $1 |
| Goodwill | $0 | $0 | $21 | $20 |
| Intangibles | $28 | $28 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $28 | $29 | $21 | $22 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $37 | $44 | $55 | $70 |
| Liabilities | – | – | – | – |
| Payables | $1 | $4 | $2 | $1 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $2 | $3 | $5 | $3 |
| Total Curr. Liab. | $4 | $7 | $7 | $4 |
| LT Debt | $0 | $0 | $0 | $1 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $3 | $0 | $0 |
| Total NC Liab. | $0 | $3 | $0 | $1 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $1 | $1 |
| Total Liabilities | $4 | $10 | $8 | $5 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$145 | -$137 | -$118 | -$96 |
| AOCI | -$0 | -$0 | $10 | $9 |
| Other Equity | $178 | $172 | $126 | $161 |
| Total Equity | $33 | $34 | $47 | $65 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $37 | $44 | $55 | $70 |
| Net Debt | -$7 | -$14 | -$15 | -$10 |